PubMed Health⌕ Search

PubMed · 9101909

[Oncologic surgery--scope and status in surgery].

Abstract

The primary goal of oncological surgery still consists of an operation which eradicates the tumor and results in an R0-resection. Comparing the various subspecialties in the different operative fields, oncological surgery unfolds its major activity in the area of visceral and thoracic surgery which is very similar in the related operative fields of gynecology and urology. Intraoperative radiation therapy is now established as an integral part of the treatment, as part of the multimodal chemotherapy currently used. Intraoperative radiation therapy offers a logical therapeutic concept in advanced tumor cases. The development of further improved prognostic factors and the addition of new molecular methods for diagnostics and therapy are probably the key future tasks in surgical oncology.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Herfarth. 1996. [Oncologic surgery--scope and status in surgery].. https://pubmed.ncbi.nlm.nih.gov/9101909/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Safe fertility-preserving management in gynecological malignancies.

OBJECTIVE: To provide a review in the available literature about the safe fertility-preserving management in gynecological malignancies, focusing on the selection criteria of the patients, treatment options and follow-up. DESIGN: Literature survey. RESULTS: The incidence of cancer in women who still want to get pregnant is increasing significantly. An early detection in gynecological malignancies allows less aggressive approaches to cure such disorders. A more conservative management, which preserves fertility, is considered safe and an option for those who have not completed their child-bearing. CONCLUSIONS: Selected patients with cervical, endometrial and ovarian cancer may be candidates to a safe fertility-preserving management. A careful stage and follow-up of the patients is essential to achieve success with this practice.

Chemotherapy, Adjuvant↗

Defining optimal therapy for muscle invasive bladder cancer.

PURPOSE: We defined an optimal curative strategy for muscle invasive bladder cancer and to determine how best to deliver curative therapy. MATERIALS AND METHODS: We reviewed published reports from 1985 to 2006 dealing with the treatment of muscle invasive (stage T2-T4a) bladder cancer. We analyzed all cohort, phase II and randomized phase III studies providing level 1 to 3 evidence impacting survival. RESULTS: Cisplatin based chemotherapy combined with high quality radical cystectomy and complete pelvic lymph node dissection improves survival over that of cystectomy alone. Surgery quality is an important predictor of survival even in patients receiving chemotherapy. Neoadjuvant chemotherapy is favored over adjuvant chemotherapy because it is better tolerated and more patients are able to receive effective therapy before rather than after surgery. CONCLUSIONS: Neoadjuvant chemotherapy followed by radical cystectomy and complete pelvic lymph node dissection is the optimal curative strategy in most patients presenting with muscle invasive bladder cancer.

Chemotherapy, Adjuvant↗